Eye drop composition for treating and preventing eye diseases and method for preparing same

Abstract

Disclosed is an eye drop composition for treating and preventing eye diseases. The eye drop composition for treating and preventing eye diseases contains, as active ingredients, minerals that have lost at least one electron, selected from germanium (Ge), silver (Ag), iridium (Ir), nickel (Ni), palladium (Pd), tantalum (Ta), antimony (Sb), zinc (Zn), indium (In), boron (B), astatine (At), thallium (Tl), magnesium carbonate (MgCO3), tin (Sn), iron (Fe), calcium sulfide (CaS), molybdenum (Mo), chromium (Cr), sodium (Na), tungsten (W), gallium (Ga), strontium (Sr), potassium (K), beryllium (Be), barium (Ba), magnesium (Mg), scandium (Sc), yttrium (Y), calcium (Ca), titanium (Ti), vanadium (V), hafnium (Hf), bromine (Br), zirconium (Zr), copper (Cu), manganese (Mn), rubidium (Rb), technetium (Tc), platinum (Pt), niobium (Nb), gold (Au), phosphate (Pi), rhenium (Re), ruthenium (Ru), cobalt (Co), zinc oxide (ZnO), aluminum (Al), selenium (Se), bismuth (Bi), phosphorus (P), rhodium (Rh), silicon (Si), iodine (I), tellurium (Te), sulfur (S), lithium (Li), osmium (Os), magnesium hydroxide (Mg(OH)2), and cesium (Cs), wherein the minerals are at least five types of minerals. The eye drop composition is very safe for the human body, and thus can be very effectively used as an eye drop agent for treating and preventing eye diseases, as well as for completely curing cataracts.

Description

Ophthalmic composition for treating and preventing eye diseases and method for producing the same

[0001] The present invention relates to an ophthalmic composition for treating and preventing eye diseases, and more particularly, to an ophthalmic composition for treating and preventing eye diseases that can remove harmful substances that accumulate in the human eye and cause eye diseases through ionic bonds and covalent bonds.

[0002]

[0003] The information contained in this background section is intended to enhance understanding of the background of the invention and may include matters that are not prior art already known to a person of ordinary skill in the art to which this technology pertains.

[0004]

[0005] Today, the atmosphere is filled with various chemicals and toxic substances, unlike the clean air before 1970, and modern people live in this atmospheric environment.

[0006] However, the body part most susceptible to airborne pollutants isn't dry skin, but rather the eyes, which are always wet. This is similar to the principle that more dust sticks to a wet rag than a dry one.

[0007] When various toxic substances and chemicals contained in the atmosphere adhere to the surface of the eye in large quantities and gradually penetrate into the eye, they accumulate and cause various eye diseases, including cataracts.

[0008] Elderly people who lived in clean air before 1980 rarely developed eye diseases like cataracts, glaucoma, and dry eye until they died after the age of 60. Developing countries with few factories and few cars still rarely suffer from cataracts because they live in pollution-free, clean air.

[0009] In developed countries where industrial development has led to increased levels of harmful substances in the atmosphere, 50-60% of people in their 60s develop the disease, and up to 80% of people in their 70s develop it. Recently, the incidence rate among people in their 30s and 40s has also been rapidly increasing.

[0010] In Japan, it was reported that approximately 66-85% of people in their 60s suffer from cataracts, approximately 84-97% of people in their 70s suffer from cataracts, and nearly 100% of people in their 80s or older suffer from cataracts.

[0011] In China, there were almost no cataract patients in the 1980s when there were few factories, but now that there are so many factories that it can be called the world's production plant, the number of cataract patients has reached a whopping 300 million, and the number of patients who undergo cataract surgery alone is as high as 3 million per year.

[0012] Situations like this are similar all over the world.

[0013] Meanwhile, in the 1970s, when there were few factories or cars and pollution was minimal, cataract cases were rare in Korea. Today, with the explosive growth of hazardous-emitting factories and the proliferation of cars, the air is so toxic that it often appears as if it's shrouded in fog, one in two people over the age of 60 suffer from cataracts, and cataract surgery is the most common surgical procedure in Korea.

[0014] When these facts are combined, it can be seen that various toxic substances and chemicals contained in the modern atmosphere adhere to the surface of the eye in large quantities and gradually penetrate into the eye, forming ionic and covalent bonds with the eye cells and accumulating in large quantities in the eye cells, causing various eye diseases, including cataracts.

[0015] Therefore, as people age, more and more harmful substances that form ionic and covalent bonds with proteins accumulate in the eyes, and when a lot of harmful substances that bind to proteins in the eyes are absorbed, these harmful substances clump together with proteins through ionic and covalent bonds, so that the proteins cannot enter the eye cells and are not utilized, and harden.

[0016] When proteins and other harmful substances clump together in the ocular epidermis through ionic or covalent bonds, hardening and forming a white film, light cannot pass through, gradually blurring vision and causing a foggy, hazy appearance. As cataracts worsen, not only can blindness occur, but symptoms such as glare and double vision can also occur.

[0017] The cause of this dreaded disease, cataracts, remains unclear to this day, and no treatment has been developed. Consequently, the only treatment available is surgery.

[0018] Meanwhile, people with diseases such as diabetes have a higher incidence of cataracts because their immune system is more weakened than healthy people, and cataracts are a disease that occurs frequently even among young people who live in areas with a lot of harmful substances.

[0019] Once cataracts develop, current treatments include using eye drops to slow their progression or surgically removing the hardened white cloudy substance, a protein clump, on the surface of the eye. Surgical treatments have made significant progress over the decades, but non-surgical methods, such as eye drops or oral medications, are not widely used due to their minimal effectiveness.

[0020] For example, Republic of Korea Patent Publication No. 10-1993-0011995 discloses an eye drop containing galanggin, a type of flavonoid used for treating cataracts, but its effect is weak and it is not used.

[0021]

[0022] The present invention aims to provide an ophthalmic composition for treating and preventing eye diseases, which can be very useful as an ophthalmic composition for treating and preventing eye diseases as well as for completely curing cataracts.

[0023] The purpose of the present invention is to provide an ophthalmic composition for treating and preventing eye diseases, which can not only cure cataracts in a short period of time, but also cure and prevent various eye diseases.

[0024] The present invention aims to provide an ophthalmic composition for treating and preventing eye diseases, which has the effect of increasing the healing effect on eye diseases such as cataracts and reducing unexpected side effects by mixing appropriate amounts of germanium (Ge) and carbon (C), which are elements that emit far-infrared rays, into the effective ingredient.

[0025] The purpose of the present invention is to provide an ophthalmic composition for treating and preventing eye diseases that does not cause any damage to the eye by adjusting the pH of the composition to pH 5 to 10, which does not cause damage to the eye, by mixing an appropriate amount of organic acid with an effective ingredient.

[0026] The present invention is 10 -12 ~10 -9 The purpose is to provide an ophthalmic composition for treating and preventing eye diseases, which can produce an effective ingredient of the composition using m.

[0027] The present invention aims to provide an ophthalmic composition for treating and preventing eye diseases, which not only has a curative and preventive effect on eye diseases including cataracts, but also is effective in that the curative and preventive effect increases as the mineral content increases, and stability in the formulation is secured.

[0028]

[0029] An ophthalmic composition for treating and preventing eye diseases according to one embodiment of the present invention comprises germanium (Ge), silver (Ag), iridium (Ir), nickel (Ni), palladium (Pd), tantalum (Ta), antimony (Sb), zinc (Zn), indium (In), boron (B), astatine (At), thallium (Tl), magnesium carbonate (MgCO3), tin (Sn), iron (Fe), calcium sulfur (CaS), molybdenum (Mo), chromium (Cr), sodium (Na), tungsten (W), gallium (Ga), strontium (Sr), potassium (K), beryllium (Be), barium (Ba), magnesium (Mg), scandium (Sc), yttrium (Y), calcium (Ca), titanium (Ti), vanadium (V), hafnium (Hf), bromine (Br), zirconium (Zr), copper (Cu), manganese (Mn), rubidium (Rb), It contains as an active ingredient a mineral that has lost at least one electron from among technetium (Tc), platinum (Pt), niobium (Nb), gold (Au), phosphate (Pi), rhenium (Re), ruthenium (Ru), cobalt (Co), zinc oxide (ZnO), aluminum (Al), selenium (Se), bismuth (Bi), phosphorus (P), rhodium (Rh), silicon (Si), iodine (I), tellurium (Te), sulfur (S), lithium (Li), osmium (Os), magnesium hydroxide (Mg(OH)2), and cesium (Cs), and the number of minerals is at least five.

[0030] Here, the active ingredients are a mixture of germanium (Ge) and carbon (C).

[0031] Additionally, the amount of germanium (Ge) and carbon (C) is 0.1 to 2 wt% of the amount of mineral.

[0032] Additionally, the active ingredient is mixed with organic acid to adjust the pH to 5 to 10.

[0033] Additionally, the content of minerals is 0.1 to 50 wt% with respect to the total weight of the composition.

[0034] Additionally, at least one of a nutrient, a hardener, a solubilizer, an oil, a preservative, a thickener, a refreshing agent, or a fragrance is added to the active ingredient.

[0035]

[0036] According to one embodiment of the present invention, a method for manufacturing an ophthalmic composition for treating and preventing eye diseases comprises: germanium (Ge), silver (Ag), iridium (Ir), nickel (Ni), palladium (Pd), tantalum (Ta), antimony (Sb), zinc (Zn), indium (In), boron (B), astatine (At), thallium (Tl), magnesium carbonate (MgCO3), tin (Sn), iron (Fe), calcium sulfur (CaS), molybdenum (Mo), chromium (Cr), sodium (Na), tungsten (W), gallium (Ga), strontium (Sr), potassium (K), beryllium (Be), barium (Ba), magnesium (Mg), scandium (Sc), yttrium (Y), calcium (Ca), titanium (Ti), vanadium (V), hafnium (Hf), bromine (Br), zirconium (Zr), copper (Cu), manganese (Mn), rubidium (Rb), A first step of applying heat of 900° C. or higher to a mineral selected from technetium (Tc), platinum (Pt), niobium (Nb), gold (Au), phosphate (Pi), rhenium (Re), ruthenium (Ru), cobalt (Co), zinc oxide (ZnO), aluminum (Al), selenium (Se), bismuth (Bi), phosphorus (P), rhodium (Rh), silicon (Si), iodine (I), tellurium (Te), sulfur (S), lithium (Li), osmium (Os), magnesium hydroxide (Mg(OH)2), and cesium (Cs) to cause the mineral to lose at least one electron; and a second step of mixing the element that has lost at least one electron and purified water in a weight ratio of 50:100 to 1:1,000 to obtain an alkaline composition, wherein the minerals are of at least five kinds.

[0037] Here, a third step of mixing an organic acid into the alkaline composition to adjust the pH to 5 to 10 is further included.

[0038]

[0039] According to the present invention, since it is very safe for the human body, it can be very usefully used as an eye drop for treating and preventing eye diseases as well as for curing cataracts.

[0040] According to the present invention, not only can cataracts be cured in a short period of time, but various eye diseases can also be cured and prevented.

[0041] According to the present invention, germanium (Ge) and carbon (C), which are elements that emit far-infrared rays, are mixed into the effective ingredient to increase the healing effect on eye diseases such as cataracts and to reduce unexpected side effects.

[0042] According to the present invention, by mixing an appropriate amount of organic acid with the effective ingredient and adjusting the pH of the composition to a pH of 5 to 10 that does not cause damage to the eye, the composition does not cause any damage to the eye.

[0043] According to the present invention, 10 -12 ~10 -9 The active ingredient of the composition can be made with m.

[0044] According to the present invention, not only can the curative and preventive effects of eye diseases including cataracts be obtained, but also the curative and preventive effects increase as the mineral content increases, making it efficient, and stability in the formulation is secured.

[0045]

[0046] Figure 1 is a flow chart of a method for manufacturing an ophthalmic composition for treating and preventing eye diseases according to one embodiment of the present invention.

[0047] FIG. 2 is a test result showing a decrease in the size of water molecule clusters when a mineral that has lost at least one electron and purified water are added at a ratio of 1:100 wt% according to one embodiment of the present invention.

[0048] Figure 3 is a schematic diagram illustrating ionic bonding according to one embodiment of the present invention.

[0049] Figure 4 is a schematic diagram illustrating a covalent bond according to one embodiment of the present invention.

[0050] FIG. 5 is a photograph of a dog's eye before instillation of an ophthalmic composition for treating and preventing eye diseases according to one embodiment of the present invention.

[0051] Figure 6 is a photograph of a dog's eye after instillation of an ophthalmic composition for treating and preventing eye diseases according to one embodiment of the present invention.

[0052] Figure 7 is an enlarged photograph of a dog's eye before instillation of an ophthalmic composition for treating and preventing eye diseases according to one embodiment of the present invention.

[0053] Figure 8 is an enlarged photograph of a dog's eye after instillation of an ophthalmic composition for treating and preventing eye diseases according to one embodiment of the present invention.

[0054]

[0055] The advantages and features of the present invention, as well as the methods for achieving them, will become clearer with reference to the following embodiments, along with the accompanying drawings. However, the present invention is not limited to the embodiments disclosed below and may be implemented in various different forms. These embodiments are provided solely to ensure a complete disclosure of the present invention and to fully convey the scope of the invention to those skilled in the art. The present invention is defined solely by the scope of the claims.

[0056]

[0057] A cataract is a disease in which the protein supplied to the epidermal layer of the eye forms an ionic or covalent bond with harmful substances, causing the clusters to grow and a white cloudy substance that cannot enter the cells of the eye covers the surface of the eye, causing loss of vision.

[0058] These 60 or so minerals, which cure cataracts and other eye diseases, are non-toxic and essential nutrients that make up the human body.

[0059] Meanwhile, the approximately 60 minerals that make up the human body are non-toxic essential nutrients. Each mineral is used to treat and prevent specific diseases: magnesium (Mg) treats muscle weakness, iron (Fe) treats anemia, zinc (Zn) treats acne, and calcium (Ca) treats osteoporosis.

[0060] If you're deficient in calcium (Ca), you'll not only develop osteoporosis, but also a staggering 147 different diseases. When you create minerals from over 60 minerals, which are incredibly effective in treating various diseases, they're absorbed in large quantities through the eyes.

[0061] That is, a lump of iron is an ionic bond between iron (Fe) elements, and when oxygen, which has a stronger bonding force than the ionic bonding force of iron (Fe), comes into contact with the lump of iron, the iron (Fe) elements combine with the oxygen and fall off from the lump of iron. This is called rust and eventually falls off.

[0062] By this same principle, harmful substances that cause cataracts by combining with proteins in the eye are removed through ionic or covalent bonds with minerals that have entered the eye, thereby completely curing cataracts.

[0063] Among the 60 or so minerals that have these amazing effects in treating and preventing various diseases, at least 5 (or more) minerals lose at least one electron and are added to water (purified water) at a rate of 10 -12 ~10 -9 The reason why this composition, dissolved in a large amount of m, penetrates more than 90% into the surface of the eye when applied to the eye is because it has been broken down into unstable, minimum unit elements that have lost electrons.

[0064] Various harmful substances on the surface of the eye form ionic or covalent bonds with proteins, forming large clusters that cannot penetrate the cells of the eye, resulting in a white cloud. These harmful substances then bond ionic or covalently with minerals, which have stronger bonds than the proteins themselves, freeing them from the proteins. This action of various minerals, which have penetrated the surface of the eye, completely cures cataracts.

[0065] Therefore, various harmful substances that are cataract-causing substances that combine with proteins to form clusters have different minerals that ionic or covalently bond with them depending on the characteristics of the substances, so an eye drop that completely cures cataracts was developed by adjusting the type of mineral that combines with them in an appropriate ratio according to the ratio of each different harmful substance.

[0066] For this reason, it is impossible to cure cataracts with only one or two minerals that have lost at least one electron in an ionic or covalent bond. At least five, and preferably at least 15 (or more) different minerals are required. This composition, which contains various minerals other than the minerals that bind to the harmful substances that cause cataracts, is remarkably effective in the treatment and prevention of various eye diseases other than cataracts by binding to and removing various harmful substances that cause various eye diseases.

[0067] In this way, the proteins and harmful substances on the surface of the eye become clusters that grow large through ionic or covalent bonds, forming a white cloudy substance that cannot enter the cells of the eye. The harmful substances form ionic or covalent bonds with minerals that have a stronger bonding force than the bonding force with proteins, and the cause of the cataract is removed, thereby completely curing the cataract.

[0068] Furthermore, we developed an eye drop that completely cures cataracts by adjusting the ratio of minerals that bind to proteins according to the ratio of various cataract-causing substances. This eye drop is used not only for cataracts but also for the treatment and prevention of various eye diseases.

[0069]

[0070] Below, we will describe in detail an ophthalmic composition for the treatment and prevention of various eye diseases, including cataracts.

[0071] Below, the mineral that has lost at least one electron can be either an organic mineral or an inorganic mineral.

[0072] Organic ionic minerals are minerals that are absorbed in large quantities by the body, but any remaining minerals are excreted without any side effects. Organic minerals are components of plants or animals. If these minerals lose at least one electron, they are almost completely absorbed by the body, even in cases of presbyopia, which reduces their digestive and absorptive capacity. Even when absorbed in large quantities, these minerals cause no side effects.

[0073] Inorganic minerals are naturally occurring minerals that are not bound to amino acids or proteins. They are abundant in water (drinking water) and minerals. However, when consumed in large quantities, unbound ionic and covalent bonds are so strong that large amounts bind to proteins in blood vessels before reaching the cells. This can lead to arteriosclerosis, as well as diseases such as gallstones and kidney stones.

[0074] Plants absorb these inorganic minerals and combine them with amino acids or proteins to form plant components. These minerals, which are plant components, are called organic minerals. Humans consume these plants to utilize them as essential nutrients (including the building blocks of the human body).

[0075] However, since the organic minerals that make up plants and animals are stabilized minerals that do not lose electrons, only about 30% of them are absorbed into the body through the small or large intestine, and they are not absorbed at all through the skin or eyes.

[0076] So, it is made of unstable minerals that have lost at least one electron from the mineral element so that they can be absorbed into the epidermis of the eye, and if several unstable minerals that have lost at least one electron are clumped together, the lumps will be large and will not be absorbed into the epidermis of the eye, so 10 -12 ~10 -9 It is to make it dissolve into m. And, when you are young, if you consume organic minerals that make up plants and animals, the amount of mineral absorption is over 60% because the acid in the stomach and intestines has good digestive power to lose at least one electron, but as you get older, the ability of the acid in the stomach and intestines to lose electrons decreases, so the amount of mineral absorption is drastically reduced to less than 30%.

[0077] Thus, young people have fewer cataract patients because they absorb more minerals that remove harmful substances combined with proteins, but as they age, their absorption of minerals that remove harmful substances combined with proteins decreases, which is one of the reasons why there are many cataract patients.

[0078]

[0079] An ophthalmic composition for treating and preventing eye diseases according to one embodiment of the present invention can be composed in various ways as follows.

[0080]

[0081] 1) An ophthalmic composition for treating and preventing eye diseases according to one embodiment of the present invention comprises germanium (Ge), silver (Ag), iridium (Ir), nickel (Ni), palladium (Pd), tantalum (Ta), antimony (Sb), zinc (Zn), indium (In), boron (B), astatine (At), thallium (Tl), magnesium carbonate (MgCO3), tin (Sn), iron (Fe), calcium sulfur (CaS), molybdenum (Mo), chromium (Cr), sodium (Na), tungsten (W), gallium (Ga), strontium (Sr), potassium (K), beryllium (Be), barium (Ba), magnesium (Mg), scandium (Sc), yttrium (Y), calcium (Ca), titanium (Ti), vanadium (V), hafnium (Hf), bromine (Br), zirconium (Zr), copper (Cu), manganese (Mn), rubidium (Rb), It contains as an active ingredient a mineral (or inorganic substance, mineral) that has lost at least one electron from among technetium (Tc), platinum (Pt), niobium (Nb), gold (Au), phosphate (Pi), rhenium (Re), ruthenium (Ru), cobalt (Co), zinc oxide (ZnO), aluminum (Al), selenium (Se), bismuth (Bi), phosphorus (P), rhodium (Rh), silicon (Si), iodine (I), tellurium (Te), sulfur (S), lithium (Li), osmium (Os), magnesium hydroxide (Mg(OH)2), and cesium (Cs), and there are at least five types of minerals.

[0082] Minerals can be extracted from any of the following: foods rich in minerals, minerals rich in minerals, herbal medicines rich in minerals, beef bones, raw materials for burdock, raw materials for cassia seeds, and shellfish.

[0083] Minerals that have lost electrons can be in powder form, with particle sizes ranging from 1.0 to 2.5 μm. To create minerals that have lost electrons, the mineral raw material is heated to temperatures above 900°C for at least 15 minutes. Even at temperatures below 1250°C, not all minerals lose at least one electron, but only a portion of them. Therefore, to completely lose electrons from all minerals, a temperature of 1250°C or higher is required.

[0084] Also, the reason minerals lose at least one electron is because they are easily absorbed through the epidermis of the eye, and only unstable elements with zero electrons exhibit excellent ionic and covalent bonding.

[0085] Since this composition is very safe for the human body, it can be very usefully used as an eye drop for treating and preventing eye diseases as well as for curing cataracts.

[0086]

[0087] 2) An ophthalmic composition for treating and preventing eye diseases according to one embodiment of the present invention comprises germanium (Ge), silver (Ag), iridium (Ir), nickel (Ni), palladium (Pd), tantalum (Ta), antimony (Sb), zinc (Zn), indium (In), boron (B), astatine (At), thallium (Tl), magnesium carbonate (MgCO3), tin (Sn), iron (Fe), calcium sulfur (CaS), molybdenum (Mo), chromium (Cr), sodium (Na), tungsten (W), gallium (Ga), strontium (Sr), potassium (K), beryllium (Be), barium (Ba), magnesium (Mg), scandium (Sc), yttrium (Y), calcium (Ca), titanium (Ti), vanadium (V), hafnium (Hf), bromine (Br), zirconium (Zr), copper (Cu), manganese (Mn), rubidium (Rb), It contains as an active ingredient a mineral that has lost at least one electron from among technetium (Tc), platinum (Pt), niobium (Nb), gold (Au), phosphate (Pi), rhenium (Re), ruthenium (Ru), cobalt (Co), zinc oxide (ZnO), aluminum (Al), selenium (Se), bismuth (Bi), phosphorus (P), rhodium (Rh), silicon (Si), iodine (I), tellurium (Te), sulfur (S), lithium (Li), osmium (Os), magnesium hydroxide (Mg(OH)2), and cesium (Cs), and the minerals are at least five types, but germanium (Ge) and carbon (C), which are elements that emit far infrared rays (InfraRed, IR), may be mixed.

[0088] Regarding minerals, it is as described in 1) above.

[0089] Far infrared rays have a longer wavelength than visible light, so when they are irradiated on the human body, they are converted into heat. Due to this characteristic, when far infrared light is irradiated on the eyes and other internal organs, it is converted into heat, dilating blood vessels and increasing blood flow to all tissues, thus increasing the supply of oxygen and nutrients.

[0090] Because of this, far infrared rays are widely used around us and are also used in the medical field for various disease treatments because they promote cell metabolism, accelerate disease healing, and reduce side effects of disease treatments.

[0091] Far infrared heat expands blood vessels and promotes blood circulation, relieving pain and is used to treat conditions such as muscle relaxation, muscle pain, joint pain, tendonitis, sprains and post-sprain rehabilitation, and chronic pain management.

[0092] In addition, the heat of far infrared rays accelerates wound healing, activates skin cells and promotes collagen production, which helps improve wrinkles, enhance skin elasticity, and treat acne. It also reduces pigmentation and relieves redness.

[0093] Germanium (Ge) and carbon (C), which are elements that emit far-infrared rays and have been shown to have various disease-treating effects and reduce various side effects of disease-treating agents as experimental results from current research, were added in an amount of 0.1 to 2 wt% to the composition, which has lost at least one electron so that it can be absorbed by the eye.

[0094] At this time, the amount of germanium (Ge) and carbon (C), which are elements that emit far-infrared rays, is 0.1 to 2% by weight of the amount of minerals, and the effective ingredient is mixed with germanium (Ge) and carbon (C), which are elements that emit far-infrared rays, to increase the healing effect on eye diseases such as cataracts and to reduce unexpected side effects.

[0095] If the amount of germanium (Ge) and carbon (C), which are elements that emit far-infrared rays, is less than 0.1 wt% of the amount of mineral, the effect is minimal, and even if the amount of germanium (Ge) and carbon (C), which are elements that emit far-infrared rays, exceeds 2 wt% of the amount of mineral, the effect does not increase further.

[0096]

[0097] 3) An ophthalmic composition for treating and preventing eye diseases according to one embodiment of the present invention comprises germanium (Ge), silver (Ag), iridium (Ir), nickel (Ni), palladium (Pd), tantalum (Ta), antimony (Sb), zinc (Zn), indium (In), boron (B), astatine (At), thallium (Tl), magnesium carbonate (MgCO3), tin (Sn), iron (Fe), calcium sulfur (CaS), molybdenum (Mo), chromium (Cr), sodium (Na), tungsten (W), gallium (Ga), strontium (Sr), potassium (K), beryllium (Be), barium (Ba), magnesium (Mg), scandium (Sc), yttrium (Y), calcium (Ca), titanium (Ti), vanadium (V), hafnium (Hf), bromine (Br), zirconium (Zr), copper (Cu), manganese (Mn), rubidium (Rb), It contains as an active ingredient a mineral that has lost at least one electron from among technetium (Tc), platinum (Pt), niobium (Nb), gold (Au), phosphate (Pi), rhenium (Re), ruthenium (Ru), cobalt (Co), zinc oxide (ZnO), aluminum (Al), selenium (Se), bismuth (Bi), phosphorus (P), rhodium (Rh), silicon (Si), iodine (I), tellurium (Te), sulfur (S), lithium (Li), osmium (Os), magnesium hydroxide (Mg(OH)2), and cesium (Cs), and the minerals are at least five kinds, and an organic acid may be mixed to adjust the pH to have 5 to 10.

[0098] Regarding minerals, it is as described in 1) above.

[0099] Because this composition is highly alkaline (pH 12 or higher), applying it directly to the eye can damage the eye's epidermis. Therefore, to lower the pH with organic acid, adding an amount equal to the mineral content of the composition will result in a neutral pH. Adding less organic acid than the mineral content will result in an alkaline pH. Adding more organic acid than the mineral content will result in an acidic pH.

[0100] It is best to mix minerals and organic acids in a 1:1 ratio to ensure a neutral pH that does not harm the eyes.

[0101] When a mineral loses at least one electron, the pH rises above 12, potentially damaging the eye. While lowering the pH with sulfuric acid or salt solutions can be beneficial, these substances are toxic and can damage the eye.

[0102] So, we discovered nutrients and organic acids that are beneficial to the eye while lowering the pH without causing eye damage. When it comes to adjusting minerals, which have lost electrons and become strongly alkaline with a pH of 12, to a pH of 5-10 that is non-hazardous to the eye, nothing beats organic acids. Organic acids are beneficial nutrients for the eye without causing any damage.

[0103] Therefore, the present composition has the effect of supplying necessary nutrients to the eye without any damage to the eye by adjusting the pH to pH 5 to 10, which does not cause damage to the eye, by mixing an appropriate amount of organic acid.

[0104] Organic acid refers to an organic compound that is acidic. Organic acid corresponds to inorganic acid, distinguishing acids derived from minerals from those derived from plants and animals as organic acids.

[0105] Since most naturally occurring organic acids are carboxylic acids, such as acetic acid, oxalic acid, tartaric acid, and benzoic acid, classical literature sometimes used the term "organic acid" to mean the same thing as other names for carboxylic acids. However, even among organic acids known since ancient times, there are non-carboxylic acids, such as uric acid. Now, with the vast number of organic compounds known, "organic acid" in a broad sense is a general term for all organic compounds possessing acidic properties.

[0106] When dissolved in water, they produce hydrogen ions in aqueous solutions, like inorganic acids, and turn blue litmus red. However, many organic acids are insoluble in water. All of these organic acids react with alkali hydroxides to form water-soluble salts. In particular, sodium salts readily dissolve in water, so organic acids that are insoluble or not very soluble in water also react with sodium hydroxide aqueous solutions, forming sodium salts and dissolving.

[0107] From a practical standpoint in organic chemistry experiments, it is convenient to treat compounds that dissolve in a 5-10% aqueous sodium hydroxide solution as acids. Organic compounds with such acidity include compounds with functional groups such as carboxylic acid RCOOH, sulfonic acid RSO3H, sulfinic acid RSO2H, phenol ArOH, enol RCH=C(OH)R', thiophenol ArSH, imide RCONHCOR', oxime RCH=NOH, aromatic sulfonamides ArSO2NH2, ArSO2NHR, and primary and secondary nitro compounds RCH2NO2, R2CHNO2.

[0108]

[0109] 4) An ophthalmic composition for treating and preventing eye diseases according to one embodiment of the present invention comprises germanium (Ge), silver (Ag), iridium (Ir), nickel (Ni), palladium (Pd), tantalum (Ta), antimony (Sb), zinc (Zn), indium (In), boron (B), astatine (At), thallium (Tl), magnesium carbonate (MgCO3), tin (Sn), iron (Fe), calcium sulfur (CaS), molybdenum (Mo), chromium (Cr), sodium (Na), tungsten (W), gallium (Ga), strontium (Sr), potassium (K), beryllium (Be), barium (Ba), magnesium (Mg), scandium (Sc), yttrium (Y), calcium (Ca), titanium (Ti), vanadium (V), hafnium (Hf), bromine (Br), zirconium (Zr), copper (Cu), manganese (Mn), rubidium (Rb), It contains minerals that have lost at least one electron from among technetium (Tc), platinum (Pt), niobium (Nb), gold (Au), phosphate (Pi), rhenium (Re), ruthenium (Ru), cobalt (Co), zinc oxide (ZnO), aluminum (Al), selenium (Se), bismuth (Bi), phosphorus (P), rhodium (Rh), silicon (Si), iodine (I), tellurium (Te), sulfur (S), lithium (Li), osmium (Os), magnesium hydroxide (Mg(OH)2), and cesium (Cs) as active ingredients, and there are at least five kinds of minerals. Germanium (Ge), an element that emits far-infrared rays, and carbon (C) may also be mixed as active ingredients, and the pH may be adjusted to 5 to 10 by mixing in an organic acid.

[0110] Regarding minerals, it is as described in 1) above.

[0111] The mixture of germanium (Ge) and carbon (C), which are elements that emit far-infrared rays, and the mixture of organic acids in the effective ingredients are as described in 2) and 3) above, respectively.

[0112]

[0113] 5) An ophthalmic composition for treating and preventing eye diseases according to one embodiment of the present invention comprises germanium (Ge), silver (Ag), iridium (Ir), nickel (Ni), palladium (Pd), tantalum (Ta), antimony (Sb), zinc (Zn), indium (In), boron (B), astatine (At), thallium (Tl), magnesium carbonate (MgCO3), tin (Sn), iron (Fe), calcium sulfur (CaS), molybdenum (Mo), chromium (Cr), sodium (Na), tungsten (W), gallium (Ga), strontium (Sr), potassium (K), beryllium (Be), barium (Ba), magnesium (Mg), scandium (Sc), yttrium (Y), calcium (Ca), titanium (Ti), vanadium (V), hafnium (Hf), bromine (Br), zirconium (Zr), copper (Cu), manganese (Mn), rubidium (Rb), It contains as an active ingredient a mineral that has lost at least one electron from among technetium (Tc), platinum (Pt), niobium (Nb), gold (Au), phosphate (Pi), rhenium (Re), ruthenium (Ru), cobalt (Co), zinc oxide (ZnO), aluminum (Al), selenium (Se), bismuth (Bi), phosphorus (P), rhodium (Rh), silicon (Si), iodine (I), tellurium (Te), sulfur (S), lithium (Li), osmium (Os), magnesium hydroxide (Mg(OH)2), and cesium (Cs), and the minerals are at least 5 kinds, and the active ingredient is 10 times more than one of purified water, water, beverage, or oil. -12 ~10 -9 It dissolves in m.

[0114] Regarding minerals, it is as described in 1) above.

[0115]

[0116] 6) An ophthalmic composition for treating and preventing eye diseases according to one embodiment of the present invention comprises germanium (Ge), silver (Ag), iridium (Ir), nickel (Ni), palladium (Pd), tantalum (Ta), antimony (Sb), zinc (Zn), indium (In), boron (B), astatine (At), thallium (Tl), magnesium carbonate (MgCO3), tin (Sn), iron (Fe), calcium sulfur (CaS), molybdenum (Mo), chromium (Cr), sodium (Na), tungsten (W), gallium (Ga), strontium (Sr), potassium (K), beryllium (Be), barium (Ba), magnesium (Mg), scandium (Sc), yttrium (Y), calcium (Ca), titanium (Ti), vanadium (V), hafnium (Hf), bromine (Br), zirconium (Zr), copper (Cu), manganese (Mn), rubidium (Rb), It contains minerals that have lost at least one electron from among technetium (Tc), platinum (Pt), niobium (Nb), gold (Au), phosphate (Pi), rhenium (Re), ruthenium (Ru), cobalt (Co), zinc oxide (ZnO), aluminum (Al), selenium (Se), bismuth (Bi), phosphorus (P), rhodium (Rh), silicon (Si), iodine (I), tellurium (Te), sulfur (S), lithium (Li), osmium (Os), magnesium hydroxide (Mg(OH)2), and cesium (Cs) as active ingredients, and there are at least five kinds of minerals, and the active ingredients are mixed with germanium (Ge), an element that emits far-infrared rays, and carbon (C), and 10 -12 ~10 -9 It can be dissolved in m.

[0117] Regarding minerals, it is as described in 1) above.

[0118] The active ingredient is a mixture of germanium (Ge) and carbon (C), which are elements that emit far-infrared rays, and 10 -12 ~10 -9 As for dissolving into m, it is as described in 2) and 5) above, respectively.

[0119]

[0120] 7) An ophthalmic composition for treating and preventing eye diseases according to one embodiment of the present invention contains a mineral that has lost at least one electron as an active ingredient, and the minerals are at least 5 kinds, and 10 kinds of the minerals are in any one of purified water, water, beverage, or oil. -12 ~10 -9 It can be dissolved in m and adjusted to have a pH of 5 to 10 that does not cause damage to the eye by mixing organic acids.

[0121] Regarding minerals, it is as described in 1) above.

[0122] The active ingredient is added to any of purified water, water, beverage or oil. -12 ~10 -9 As for dissolving in m and mixing with organic acids, they are as described in 5) and 3) above, respectively.

[0123]

[0124] 8) An ophthalmic composition for treating and preventing eye diseases according to one embodiment of the present invention contains a mineral that has lost at least one electron as an active ingredient, and the minerals are of at least five types, and an element that emits far infrared rays is mixed, and 10 -12 ~10 -9 It is soluble in m and can be adjusted to have a pH of 5 to 10 that is not harmful to the eye by mixing organic acids.

[0125] Regarding minerals, it is as described in 1) above.

[0126] A mixture of germanium (Ge) and carbon (C), which are elements that emit far-infrared rays, in the active ingredient, 10 -12 ~10 -9 Regarding the dissolution in m and the mixing of organic acids, they are as described in 2), 5), and 3) above, respectively.

[0127]

[0128] Meanwhile, the mineral content may range from 0.1 to 50 wt% based on the total weight of the compositions described above. If the mineral content is less than 0.1 wt%, the curative and preventive effects on eye diseases, including cataracts, are minimal. If the mineral content exceeds 50 wt%, the curative and preventive effects do not increase with increasing mineral content, resulting in ineffectiveness and inability to ensure formulation stability.

[0129] In this regard, when five or more active ingredients that have lost at least one electron are mixed in an amount of 0.1 to 50 wt% based on the total weight of the composition, purified water and organic acids, etc. are mixed in pico units (10 ) that are much smaller than nano units. -12 ~10 -9 m) is broken down into pico units (10) which are much smaller than nano units. -12 ~10 -9 m) must be broken down to enter the eye cells when the eye drops are put into the eye.

[0130] If the element that causes electron loss is added in an amount less than 0.1% by weight of the total weight of the composition, the other active ingredients, including purified water, will not be broken down into nano-sized particles, so they will not be able to penetrate into the eye, resulting in minimal treatment effects for eye diseases. However, if the element that causes electron loss is added in an amount greater than 0.1% by weight of the total weight of the composition, the pH may become higher than 10, which may damage the eye. Therefore, to prevent eye damage, an organic acid is mixed to adjust the pH to a level that does not damage the eye.

[0131] Therefore, not only can the effect of curing and preventing eye diseases including cataracts be obtained only when the content of minerals is 0.1 to 50 wt%, but the curing and preventing effect also increases as the content of minerals increases to 0.1 or more, making it efficient and ensuring stability in the formulation.

[0132]

[0133] Meanwhile, below, we will examine the manufacturing method for the eye drop composition for treating and preventing eye diseases discussed above.

[0134] FIG. 1 is a flow chart of a method for manufacturing an ophthalmic composition for treating and preventing eye diseases according to an embodiment of the present invention, and FIG. 2 is a test report measuring a decrease in the size of water molecule groups (clusters) by adding a mineral that has lost at least one electron and purified water in a ratio of 1:100 wt% according to an embodiment of the present invention.

[0135] Referring to FIGS. 1 to 5, a method for manufacturing an ophthalmic composition for treating and preventing eye diseases may include S100 to S400.

[0136] First, germanium (Ge), silver (Ag), iridium (Ir), nickel (Ni), palladium (Pd), tantalum (Ta), antimony (Sb), zinc (Zn), indium (In), boron (B), astatine (At), thallium (Tl), magnesium carbonate (MgCO3), tin (Sn), iron (Fe), calcium sulfate (CaS), molybdenum (Mo), chromium (Cr), sodium (Na), tungsten (W), gallium (Ga), strontium (Sr), potassium (K), beryllium (Be), barium (Ba), magnesium (Mg), scandium (Sc), yttrium (Y), calcium (Ca), titanium (Ti), vanadium (V), hafnium (Hf), bromine (Br), zirconium (Zr), copper (Cu), manganese (Mn), rubidium (Rb), technetium (Tc), platinum (Pt), A mineral selected from niobium (Nb), gold (Au), phosphate (Pi), rhenium (Re), ruthenium (Ru), cobalt (Co), zinc oxide (ZnO), aluminum (Al), selenium (Se), bismuth (Bi), phosphorus (P), rhodium (Rh), silicon (Si), iodine (I), tellurium (Te), sulfur (S), lithium (Li), osmium (Os), magnesium hydroxide (Mg(OH)2), and cesium (Cs) is heated to 900°C or higher to cause the mineral to lose at least one electron (S100). Preferably, the heat applied to the mineral is 1250°C or higher. This is because a temperature of 1250°C is required for all minerals to lose at least one electron. There are at least five types of minerals.

[0137] In other words, when minerals are heated below 1250℃, only some minerals lose one or more electrons. However, when minerals are heated above 1250℃, all minerals lose one or more electrons, resulting in minerals with a high ionic or covalent bonding effect. Therefore, the optimal temperature for creating minerals that have lost one or more electrons is 1250℃ or higher.

[0138] In addition, various harmful substances that accumulate on the surface of the eye and cause various eye diseases, including cataracts, have different mineral components that are ionic or covalently bonded depending on the characteristics of each substance.

[0139] For this reason, the type and content of minerals that form ionic and covalent bonds are prepared in an appropriate ratio according to the type and content ratio of harmful substances accumulated on the surface of the eye, and high heat of 1250℃ or higher is applied to cause the loss of at least one electron.

[0140] After S100, an alkaline composition is obtained by mixing elements that have lost at least one electron and purified water in a weight ratio of 50:100 to 1:1,000 (S200). Preferably, the weight ratio of the five elements that have lost at least one electron and purified water is 1:400 to 1:600.

[0141] When minerals that have lost at least one electron are mixed with water (purified water, etc.) at a weight ratio of S200 and stirred well, most of the minerals that have lost at least one electron will be 10 -12 ~10 -9 Not only does it dissolve in water, it is also broken down to less than 60Hz, which allows water clusters of up to 120Hz to enter the cells.

[0142] Although minerals that have lost one or more electrons can be mixed with purified water at a weight ratio of 50:100, this is ineffective because the cataract-reducing effect is similar to that of compositions mixed at a weight ratio of 1:50 to 1:100. A 1:1,000 weight ratio of minerals that have lost at least one electron to purified water also has a therapeutic effect, but the effect is low.

[0143] After S200, the alkaline composition is mixed with an organic acid to adjust the pH to a slightly alkaline level of 5-10 (S300). The organic acid is mixed to lower the pH. If the amount of organic acid added is equal to the mineral content of the composition, the pH becomes neutral. If the amount of organic acid added exceeds the mineral content, the pH becomes acidic. In other words, a pH of 7 is neutral, a pH of 7 or higher is alkaline, and a pH of 7 or lower is acidic.

[0144] In order to adjust the pH to 5-10 by mixing organic acid into the alkaline composition, the organic acid must be mixed in an amount less than the mineral content.

[0145] After S300, the settled components, such as minerals and organic acids, are filtered out (S400). This is because these settled components are not easily absorbed into the eye, making them ineffective in treating cataracts and other eye diseases. Therefore, they must be filtered out to avoid being mistaken for impurities.

[0146]

[0147] Figure 3 is a schematic diagram illustrating ionic bonding according to one embodiment of the present invention.

[0148] Referring to Figure 3, an ionic bond refers to a bond formed by the exchange of electrons between atoms. Sodium (Na) has only one electron in its outermost shell, while chlorine (Cl) has seven electrons in its outermost shell. According to the octet rule, atoms tend to maintain a minimum number of electrons in their outermost shell of eight.

[0149] When sodium (Na) and chlorine (Cl) approach each other, sodium (Na) tries to give one of its remaining electrons to chlorine (Cl), and chlorine (Cl) tries to receive one of its missing electrons from sodium (Na).

[0150] In this way, when sodium (Na) donates one electron to chlorine (Cl), sodium (Na) becomes positively charged and chlorine (Cl) becomes negatively charged. An attractive force occurs between the positive and negative charges, and as a result, the two atoms combine. This is how sodium chloride (NaCl) is created.

[0151]

[0152] Figure 4 is a schematic diagram illustrating a covalent bond according to one embodiment of the present invention.

[0153] Referring to Figure 4, a covalent bond is not a bond in which an atom unilaterally gives electrons to another atom, but rather a bond that is formed when two atoms release electrons from each other to form an electron pair and share it.

[0154] Two chlorine atoms each donate one electron to create an electron pair, which they then share to form a bond.

[0155] A bond that is electrically neutral and shares electrons to form a stable electron configuration is called a covalent bond.

[0156]

[0157] Meanwhile, in order to verify the superiority and reliability of the cataract treatment effect of the ophthalmic composition for treating and preventing eye diseases according to one embodiment of the present invention, the following experiment was conducted.

[0158] In this experiment, the composition (containing at least one electron-depleted germanium (Ge), iron (Fe), strontium (Sr), calcium (Ca), copper (Cu), manganese (Mn), magnesium (Mg), zinc (Zn), potassium (K), silicon (Si), and sodium (Na) as active ingredients) was instilled into the eyes of a 10-year-old dog with severe cataracts that made the dog blind, 5 times a day for 30 days, for a total of 150 times. Instillations were made at equal time intervals at 9:00 AM, 11:00 AM, 1:00 PM, 3:00 PM, and 5:00 PM each day, and the dosage for each eye drop was one drop.

[0159] Figures 5 to 8 below show the experimental results.

[0160]

[0161] FIG. 5 is a photograph of a dog's eye before instilling an ophthalmic composition for treating and preventing eye diseases according to an embodiment of the present invention. FIG. 6 is a photograph of a dog's eye after instilling an ophthalmic composition for treating and preventing eye diseases according to an embodiment of the present invention. FIG. 7 is an enlarged photograph of a dog's eye before instilling an ophthalmic composition for treating and preventing eye diseases according to an embodiment of the present invention. FIG. 8 is an enlarged photograph of a dog's eye after instilling an ophthalmic composition for treating and preventing eye diseases according to an embodiment of the present invention.

[0162] Referring to FIGS. 5 to 8, the changed appearance of the dog's eyes before and after instillation of the composition (germanium (Ge), iron (Fe), strontium (Sr), calcium (Ca), copper (Cu), manganese (Mn), magnesium (Mg), zinc (Zn), potassium (K), silicon (Si), and sodium (Na) having lost at least one electron) can be compared.

[0163] As shown in FIGS. 4 and 6, prior to instillation of the composition, a white color appears above the dog's eye, indicating that the dog has cataracts. However, as shown in FIGS. 5 and 7, after instillation of the composition, no white color appears above the dog's eye, indicating that the cataracts have been completely cured.

[0164] These experimental results demonstrate that the composition completely cured cataracts by removing cataract-causing substances through ionic and covalent bonds.

[0165] Through this, the present composition clearly demonstrates that it is an effective substance for treating and preventing eye diseases including cataracts.

[0166] While two months is sufficient for complete cure of severe cataracts in animals using this composition, it takes approximately six to eight times longer for complete cure of severe cataracts in humans than in animals. The effective ingredients of this composition may include at least one of a far-infrared ray emitting component, a preservative, a buffer, an isotonic agent, a solubilizer, a stabilizer, a chelating agent, a thickener, a cooling agent, and a fragrance.

[0167] This composition has the same effect as in humans in treating and preventing eye diseases, including curing cataracts in animals other than humans (including mammals, livestock such as pigs, cows, horses, dogs, and pets), and can therefore also be used to treat eye diseases in animals.

[0168] All conventional eye drops for treating eye diseases have serious side effects that can lead to blindness if used more than 1 to 3 times a day, so the recommended number of eye drops per day is 1 to 3 times.

[0169] However, since this composition is an eye drop that contains no chemical ingredients including steroids or antibiotics and is 100% made up of only nutrients necessary for the human body, the treatment will be faster the more frequently you instill 1 to 2 drops of this composition into your eyes 5 or more times per day, and preferably, the treatment will be faster if you instill it 10 to 15 times a day.

[0170] There is no limit to the daily dosage of eye drops. The more frequently you use them, the faster the treatment of eye diseases, including cataracts. The frequency of use can vary depending on the individual's medical condition. Furthermore, there are no specific restrictions on the duration of administration, with longer periods of use leading to better results.

[0171]

[0172] Below, the excellence and reliability of an ophthalmic composition for treating and preventing eye diseases according to one embodiment of the present invention will be demonstrated through Examples 1 and 2.

[0173]

[0174] [Example 1]

[0175] Cataract severity is the percentage of the eye area covered by white turbidity. In order to measure the cataract cure effect, a total of 21 dogs were administered the composition (containing at least one electron-lost germanium (Ge), iron (Fe), strontium (Sr), calcium (Ca), copper (Cu), manganese (Mn), magnesium (Mg), zinc (Zn), potassium (K), silicon (Si), and sodium (Na) as active ingredients) to measure the cataract cure effect.

[0176] The daily number of eye drops is five, with one drop per eye and two drops for both eyes. The removal rate and treatment results for each condition according to the amount of white turbidity are shown in Table 1.

[0177]

[0178] Amount of white turbidity If you use eye drops 5 times a day (for 30 days), the rate of removal of white turbidity If you use eye drops 5 times a day (for 60 days), the rate of removal of white turbidity Treatment result: 70% or more All 60% 4 dogs 100%, 1 dog 97% Only 4 dogs completely cured 50% All 80% All 100% All completely cured 33% All 100% - All completely cured

[0179]

[0180] [Example 2]

[0181] In Example 1 above, only animal clinical trials were conducted for the complete cure of cataracts, but in order to measure the extent to which the composition (containing as active ingredients germanium (Ge), iron (Fe), strontium (Sr), calcium (Ca), copper (Cu), manganese (Mn), magnesium (Mg), zinc (Zn), potassium (K), silicon (Si), and sodium (Na) that have lost at least one electron)) has a curative effect on various eye diseases other than cataracts, a clinical trial was conducted on 19 patients with various eye diseases.

[0182] A clinical trial was conducted to evaluate the effectiveness of treating various eye diseases on a total of 7 patients with eye diseases: 3 patients with astigmatism, 8 patients with dry eye, 2 patients with glaucoma, 1 patient with an eye disease that caused a lot of heat in the eyes and always had red eyes, 2 patients with an eye disease that made driving at night difficult due to severe light reflection, 2 patients with an eye disease that caused itching in and around the eyes and blurred vision, and 1 patient with Sjogren's syndrome.

[0183]

[0184] In this clinical trial, the number of daily eye drops was 10, with one drop per eye and two drops total for both eyes. The therapeutic effects and outcomes for each condition according to the disease are shown in Table 2.

[0185]

[0186] Symptoms Treatment effect in case of 60 days of eye drops Treatment effect in case of 150 days of eye drops Treatment result Floaters 100% cured - cured Dry eye 50% cured 90% recovered Glaucoma 15% cured 30% cured Eye irritation 80% cured 100% cured Cured in case of 150 days of eye drops Itchy eyes 100% cured - cured Sjogren's syndrome 80% or more cured 100% cured Cured in case of 150 days of eye drops Light reflex patients 70% cured 100% cured Cured in case of 150 days of eye drops

[0187]

[0188] The eye drops corresponding to the composition of the present invention, which have shown surprising and groundbreaking clinical results, such as a miracle that no one could have predicted, will bring about a great innovation in the treatment theory of various ophthalmic diseases in the future.

[0189] Not only that, it will cure various eye diseases in a short period of time at a cost of less than 10% of the cost of eye hospital treatment, and will eliminate the suffering of over 1 billion eye disease patients around the world.

[0190]

[0191] For reference, regarding the ophthalmic composition for treating and preventing eye diseases according to one embodiment of the present invention, the inventors of the present invention have discovered for the first time, after over 20 years of research, that the cause of cataracts is various harmful substances that ionic and covalently bond with proteins. Furthermore, after over a decade of research, they have also discovered for the first time in the world that the components capable of removing harmful substances that cause cataracts and various eye diseases are various minerals that have lost at least one electron, thereby completing the present invention.

[0192] A cataract cure has been developed that completely cures cataracts without any side effects and various eye diseases such as floaters and dry eye by removing various harmful substances accumulated in the eye, which are the cause of various eye diseases including cataracts. Therefore, from now on, it will be of great help to more than 1 billion people suffering from various eye diseases such as cataracts, floaters, and dry eye.

[0193] Also, when you put this composition of eye drops into your eyes, they immediately feel rough as if sand has gotten into them. This is because the harmful substances that are adsorbed to the eyeball and stuck to it like dirt are ionically and covalently bonded with the components of the eye drop and fall off from the eyeball and clump together.

[0194] Using eye drops containing this composition for about a month will remove all harmful substances that have adhered to the eyeball, leaving the eye free of any grime. Simply removing these harmful substances from the eye surface can delay or halt the progression of various eye diseases and even restore impaired vision.

[0195] Cataract cures are excellent at removing various harmful substances accumulated in the eyes, so even people who do not have eye diseases including cataracts can prevent various eye diseases including cataracts by instilling them into the eyes once or twice a day to remove only the harmful substances that are invisible to the eye but are bound and attached to the surface of the eyes.

[0196] The principle by which harmful substances that are bound and attached to the surface of the eye are removed is that the harmful substances in the surface layer of the eye and minerals that have lost at least one electron form ionic or covalent bonds, as explained above.

[0197]

[0198] While the embodiments of the present invention described above have been described with reference to the drawings to aid understanding, these are merely exemplary, and those skilled in the art will understand that various modifications and equivalent embodiments are possible. Therefore, the true scope of technical protection of the present invention should be defined by the appended claims.

Claims

1. Germanium (Ge), silver (Ag), iridium (Ir), nickel (Ni), palladium (Pd), tantalum (Ta), antimony (Sb), zinc (Zn), indium (In), boron (B), astatine (At), thallium (Tl), magnesium carbonate (MgCO3), tin (Sn), iron (Fe), calcium sulfur (CaS), molybdenum (Mo), chromium (Cr), sodium (Na), tungsten (W), gallium (Ga), strontium (Sr), potassium (K), beryllium (Be), barium (Ba), magnesium (Mg), scandium (Sc), yttrium (Y), calcium (Ca), titanium (Ti), vanadium (V), hafnium (Hf), bromine (Br), zirconium (Zr), copper (Cu), manganese (Mn), rubidium (Rb), technetium (Tc), platinum (Pt), An ophthalmic composition for treating and preventing eye diseases, comprising as an active ingredient at least one electron-loss mineral from among niobium (Nb), gold (Au), phosphate (Pi), rhenium (Re), ruthenium (Ru), cobalt (Co), zinc oxide (ZnO), aluminum (Al), selenium (Se), bismuth (Bi), phosphorus (P), rhodium (Rh), silicon (Si), iodine (I), tellurium (Te), sulfur (S), lithium (Li), osmium (Os), magnesium hydroxide (Mg(OH)2), and cesium (Cs), wherein the minerals are of at least five types.

2. In paragraph 1, An ophthalmic composition for treating and preventing eye diseases, characterized in that the above effective ingredient is a mixture of germanium (Ge) and carbon (C).

3. In paragraph 2, An ophthalmic composition for treating and preventing eye diseases, characterized in that the amount of the germanium (Ge) and the carbon (C) is 0.1 to 2 wt% of the amount of the mineral.

4. In paragraph 1 or 2, An ophthalmic composition for treating and preventing eye diseases, characterized in that the above effective ingredient is adjusted to have a pH of 5 to 10 by mixing organic acids.

5. In paragraph 1, An ophthalmic composition for treating and preventing eye diseases, characterized in that the content of the mineral is 0.1 to 50 wt% based on the total weight of the composition.

6. In paragraph 2, An ophthalmic composition for treating and preventing eye diseases, characterized in that the above active ingredient comprises at least one of a nutrient, a hardener, a solubilizer, an oil, a preservative, a thickener, a refreshing agent, or a fragrance.

7. Germanium (Ge), silver (Ag), iridium (Ir), nickel (Ni), palladium (Pd), tantalum (Ta), antimony (Sb), zinc (Zn), indium (In), boron (B), astatine (At), thallium (Tl), magnesium carbonate (MgCO3), tin (Sn), iron (Fe), calcium sulfur (CaS), molybdenum (Mo), chromium (Cr), sodium (Na), tungsten (W), gallium (Ga), strontium (Sr), potassium (K), beryllium (Be), barium (Ba), magnesium (Mg), scandium (Sc), yttrium (Y), calcium (Ca), titanium (Ti), vanadium (V), hafnium (Hf), bromine (Br), zirconium (Zr), copper (Cu), manganese (Mn), rubidium (Rb), technetium (Tc), platinum (Pt), A first step of applying heat of 900°C or higher to a mineral selected from niobium (Nb), gold (Au), phosphate (Pi), rhenium (Re), ruthenium (Ru), cobalt (Co), zinc oxide (ZnO), aluminum (Al), selenium (Se), bismuth (Bi), phosphorus (P), rhodium (Rh), silicon (Si), iodine (I), tellurium (Te), sulfur (S), lithium (Li), osmium (Os), magnesium hydroxide (Mg(OH)2), and cesium (Cs) to cause the mineral to lose at least one electron; and A second step of obtaining an alkaline composition by mixing the element that has lost at least one electron and purified water in a weight ratio of 50:100 to 1:1,000. A method for producing an ophthalmic composition for treating and preventing eye diseases, comprising at least five types of minerals.

8. In paragraph 7, A method for producing an ophthalmic composition for treating and preventing eye diseases, characterized in that it further includes a third step of adjusting the pH to 5 to 10 by mixing an organic acid into the alkaline composition.

Images